Victoria Wolodzko Smart, Senior Vice President at Mission at Susan G. Komen, shared a post on LinkedIn:
“Research saves lives, across all health conditions, across all communities.
At Susan G. Komen we’ve come together with a coalition of cancer leaders representing the millions of patients impacted by breast, colorectal, lung, pancreatic, and prostate cancers, joining with AACI (Association of American Cancer Institutes) to underscore the critical importance of sustaining cancer research funding.
For more than five decades, federal investments in cancer research have helped transform what was once a terminal diagnosis into a survivable disease for millions of Americans.
Today, more than 18 million people in the United States are cancer survivors – nearly six times as many as when the National Cancer Act was signed in 1971. In breast cancer, we’ve reduced the mortality rate by 44%!
This extraordinary progress is a testament to what is possible when research is prioritized, and patients are at the center of innovation. However, our work is not done. Millions of Americans are still being diagnosed with and dying from cancer each year.
The investments that drive progress are now at grave risk.
Read our full statement.
Thank you to: Courtney Bugler, (CFRE, President and CEO at ZERO Prostate Cancer), Anjee Davis, (CEO at Fight Colorectal Cancer), Andrea Ferris, (President and CEO at LUNGevity Foundation), Julie Fleshman, (President and CEO at Pancreatic Cancer Action Network), Jennifer Pegher (Executive Director at AACI).”
More posts featuring Victoria Wolodzko Smart.